| Improving the results of coronary angioplasty. | |
| | |
MedLine Citation:
|
PMID: 9448907 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Coronary angioplasty has changed dramatically in the past three years with major reductions in suboptimal results and restenosis rates, and improvements in safety, efficacy and cost-effectiveness. Intracoronary stent implantation with optimisation of strut expansion and the abandonment of anticoagulants after deployment, have led to less entry-site complications, facilitated early hospital discharge, virtually abolished subacute stent thrombosis and resulted in a 50% reduction in target vessel revascularisation. Adjuvant medical treatment with anti-platelet agents, including glycoprotein IIb/IIIa receptor inhibitors, improves the safety of angioplasty and may further reduce the restenosis rate. Selective use of debulking devices has extended the indications for angioplasty. High resolution fluoroscopy, quantitative coronary angiography and intracoronary ultrasound leading to improved diagnosis, equipment selection and treatment have contributed to better outcomes. Further clinical trials will compare angioplasty and stent implantation with coronary bypass surgery in patients with multivessel coronary disease, and may extend the indications for percutaneous transluminal coronary angioplasty (PTCA) to selected patients with three vessel disease. |
| | |
Authors:
|
C N Aroney |
Related Documents
:
|
2952607 - Emergency percutaneous transluminal coronary angioplasty without thrombolysis as initia... 10820937 - The "hybrid" approach for revascularisation: direct myocardial revascularisation and co... 15708697 - Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for pati... 2896457 - Protection of the ischemic myocardium during percutaneous transluminal coronary angiopl... 21818697 - Strategies for tissue engineering cardiac constructs to affect functional repair follow... 2327357 - Heparin and infarct coronary artery patency after streptokinase in acute myocardial inf... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Australian and New Zealand journal of medicine Volume: 27 ISSN: 0004-8291 ISO Abbreviation: Aust N Z J Med Publication Date: 1997 Aug |
Date Detail:
|
Created Date: 1998-03-18 Completed Date: 1998-03-18 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 1264322 Medline TA: Aust N Z J Med Country: AUSTRALIA |
Other Details:
|
Languages: eng Pagination: 510-4 Citation Subset: IM |
Affiliation:
|
Prince Charles Hospital, Brisbane, Qld. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary*
/
methods,
standards,
trends Atherectomy / methods, standards, trends Blood Vessel Prosthesis Implantation / methods, standards, trends Coronary Angiography Coronary Disease / radiography, therapy* Fibrinolytic Agents / therapeutic use Humans Safety Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Interventional management of acute myocardial infarction (AMI).
Next Document: Evidence-based cardiac practice.